InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+21.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Dagnon Terry. Director active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. Breakdown: 3 buys · 1 sell. Total volume traded: €591k. History available since 3 December 2021. The latest transaction was disclosed on 20 April 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Dagnon Terry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
520,000 shares@ US$1.13584.8% of flowCommon StockSEC:0001209191-23-025294:0
10,000 shares@ US$1.050.0069% mcap10.3% of flowCommon StockSEC:0001209191-22-038989:0
Canonical exit: 19 Sept 2022 (T+90)
25,201 shares@ US$1.385.2% of flowCommon StockSEC:0001209191-21-068135:0
Canonical exit: 6 Mar 2022 (T+90)
10,000 shares@ US$1.422.1% of flowCommon StockSEC:0001209191-21-067838:0
Canonical exit: 3 Mar 2022 (T+90)
4 of 4 declarations
About Dagnon Terry
Terry Dagnon is a director at Outlook Therapeutics, Inc.
